FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128520342> ?p ?o ?g. }

• W3128520342 endingPage "1631" @default.
• W3128520342 startingPage "1631" @default.
• W3128520342 abstract "Angiogenesis is one of the hallmarks of cancer. Several studies have shown that vascular endothelium growth factor (VEGF) plays a leading role in angiogenesis progression. Antiangiogenic medication has gained substantial recognition and is commonly administered in many forms of human cancer, leading to a rising interest in cancer therapy. However, this treatment method can lead to a deteriorating outcome of resistance, invasion, distant metastasis, and overall survival relative to its cytotoxicity. Furthermore, there are significant obstacles in tracking the efficacy of antiangiogenic treatments by incorporating positive biomarkers into clinical settings. These shortcomings underline the essential need to identify additional angiogenic inhibitors that target numerous angiogenic factors or to develop a new method for drug delivery of current inhibitors. The great benefits of nanoparticles are their potential, based on their specific properties, to be effective mechanisms that concentrate on the biological system and control various important functions. Among various therapeutic approaches, nanotechnology has emerged as a new strategy for treating different cancer types. This article attempts to demonstrate the huge potential for targeted nanoparticles and their molecular imaging applications. Notably, several nanoparticles have been developed and engineered to demonstrate antiangiogenic features. This nanomedicine could effectively treat a number of cancers using antiangiogenic therapies as an alternative approach. We also discuss the latest antiangiogenic and nanotherapeutic strategies and highlight tumor vessels and their microenvironments." @default.
• W3128520342 created "2021-02-15" @default.
• W3128520342 creator A5043847178 @default.
• W3128520342 creator A5044602966 @default.
• W3128520342 creator A5046061905 @default.
• W3128520342 creator A5048696566 @default.
• W3128520342 creator A5052762616 @default.
• W3128520342 creator A5084450743 @default.
• W3128520342 creator A5089202784 @default.
• W3128520342 creator A5090444613 @default.
• W3128520342 date "2021-02-05" @default.
• W3128520342 modified "2023-10-17" @default.
• W3128520342 title "Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine" @default.
• W3128520342 cites W1772470385 @default.
• W3128520342 cites W1964649132 @default.
• W3128520342 cites W1970107343 @default.
• W3128520342 cites W1970203323 @default.
• W3128520342 cites W1970369740 @default.
• W3128520342 cites W1983030304 @default.
• W3128520342 cites W1985126174 @default.
• W3128520342 cites W1989363331 @default.
• W3128520342 cites W1989402742 @default.
• W3128520342 cites W1992112921 @default.
• W3128520342 cites W1993016882 @default.
• W3128520342 cites W1999966784 @default.
• W3128520342 cites W2005082473 @default.
• W3128520342 cites W2010555185 @default.
• W3128520342 cites W2017322644 @default.
• W3128520342 cites W2017818795 @default.
• W3128520342 cites W2025016054 @default.
• W3128520342 cites W2030537668 @default.
• W3128520342 cites W2032995169 @default.
• W3128520342 cites W2034564620 @default.
• W3128520342 cites W2037281949 @default.
• W3128520342 cites W2046318151 @default.
• W3128520342 cites W2069361214 @default.
• W3128520342 cites W2072889522 @default.
• W3128520342 cites W2074196937 @default.
• W3128520342 cites W2075282478 @default.
• W3128520342 cites W2076704022 @default.
• W3128520342 cites W2085273836 @default.
• W3128520342 cites W2086775675 @default.
• W3128520342 cites W2087408058 @default.
• W3128520342 cites W2093088471 @default.
• W3128520342 cites W2094841478 @default.
• W3128520342 cites W2105192980 @default.
• W3128520342 cites W2108042184 @default.
• W3128520342 cites W2115686439 @default.
• W3128520342 cites W2115914766 @default.
• W3128520342 cites W2116118767 @default.
• W3128520342 cites W2118677643 @default.
• W3128520342 cites W2125561465 @default.
• W3128520342 cites W2139705476 @default.
• W3128520342 cites W2142781307 @default.
• W3128520342 cites W2145036915 @default.
• W3128520342 cites W2145835533 @default.
• W3128520342 cites W2149456801 @default.
• W3128520342 cites W2157769714 @default.
• W3128520342 cites W2158474413 @default.
• W3128520342 cites W2165626810 @default.
• W3128520342 cites W2167139020 @default.
• W3128520342 cites W2167188058 @default.
• W3128520342 cites W2168587151 @default.
• W3128520342 cites W2169633689 @default.
• W3128520342 cites W2170932239 @default.
• W3128520342 cites W2226125668 @default.
• W3128520342 cites W2238317307 @default.
• W3128520342 cites W2256492013 @default.
• W3128520342 cites W2309208903 @default.
• W3128520342 cites W2321359285 @default.
• W3128520342 cites W2322861634 @default.
• W3128520342 cites W2409041580 @default.
• W3128520342 cites W2411323646 @default.
• W3128520342 cites W2416232859 @default.
• W3128520342 cites W2418529341 @default.
• W3128520342 cites W2479083401 @default.
• W3128520342 cites W2487348170 @default.
• W3128520342 cites W2509768156 @default.
• W3128520342 cites W2510510589 @default.
• W3128520342 cites W2516305484 @default.
• W3128520342 cites W2516702596 @default.
• W3128520342 cites W2524872195 @default.
• W3128520342 cites W2530952499 @default.
• W3128520342 cites W2557261433 @default.
• W3128520342 cites W2560771902 @default.
• W3128520342 cites W2571164517 @default.
• W3128520342 cites W2584750294 @default.
• W3128520342 cites W2598967510 @default.
• W3128520342 cites W2605407725 @default.
• W3128520342 cites W2614982847 @default.
• W3128520342 cites W2618270895 @default.
• W3128520342 cites W2618634810 @default.
• W3128520342 cites W2734602934 @default.
• W3128520342 cites W2739460332 @default.
• W3128520342 cites W2741312435 @default.
• W3128520342 cites W2743701252 @default.
• W3128520342 cites W2747016053 @default.
• W3128520342 cites W2749019792 @default.

• next